Diagnostic Role of Anti-Nuclear Antibodies in Rheumatic Diseases
Turkish Journal of Rheumatology, 06/26/2012
B Murat– Anti–Nuclear Antibodies (ANA) testing may provide important data for an upcoming rheumatic disease, be valuable in the diagnosis and prognosis prediction. ANA can be measured in two ways; one is the generic ANA for overall evaluation and the second is specific antibody detection for specific diseases. A competent clinician should well know the symptoms and clinical findings of the various RD’s and should rationally use the laboratory findings as a supplementary diagnostic method.